Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$38.16 - $48.86 $10,951 - $14,022
-287 Reduced 5.02%
5,426 $262,000
Q4 2022

Feb 14, 2023

BUY
$33.53 - $54.79 $191,556 - $313,015
5,713 New
5,713 $218,000
Q4 2021

Feb 14, 2022

SELL
$35.36 - $41.86 $454,057 - $537,524
-12,841 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$37.01 - $44.74 $384,459 - $464,759
10,388 Added 423.48%
12,841 $478,000
Q1 2020

May 15, 2020

SELL
$32.37 - $59.36 $1,068 - $1,958
-33 Reduced 1.33%
2,453 $109,000
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $26,065 - $40,506
809 Added 48.24%
2,486 $119,000
Q2 2019

Aug 14, 2019

BUY
$35.42 - $45.0 $59,399 - $75,465
1,677 New
1,677 $75,000
Q3 2017

Nov 14, 2017

SELL
$16.81 - $21.61 $1,680 - $2,161
-100 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
100
100 $2,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.